While gain of function mutations affecting PolI components are not frequent and are mostly associated with hereditary diseases rather than with cancer [22,23], tumor cells boost rRNA biogenesis mainly through the overexpression of genes involved in PolI-mediated transcription and through the stimulation of their activity, which is directly controlled by oncogenic signaling pathways. This evidence concerns the gene ENSG00000223804 and hereditary disease.